They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...

“Mounjaro is the brand name for tirzepatide, a weekly injectable weight-loss medication which has recently been approved for ...

Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...

As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...

A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

The latest Health Survey for England shows that 64% of adults were overweight or obese in 2022. However, Dr Kath McCullough, ...

Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the ...

Earlier this year, the Labour government announced plans to roll out weight-loss jab Mounjaro on the NHS, to help combat obesity levels in Britain and get unemployed people back to work. Although the ...

The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body mass index (BMI) of more than 35 and at least one weight-related illness.

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.